Sanofi Pharma Day 2021

October 18, 2021 8:00 AM - 6:00 PM

MassBioHub & Virtual, 700 Technology Sq Fl 5 Cambridge MA 02139

Add to Calendar 10/18/2021 8:00:00 AM 10/18/2021 6:00:00 PM Sanofi Pharma Day 2021

Accelerate your emerging company or idea at Sanofi’s 2021 Pharma Days on October 18 & 19.  
 

MassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. 

Please note that in-person attendees are required to be fully vaccinated to participate in the event. Additionally, masks will be required in all common areas of the event space except for when eating or drinking; in meeting rooms, attendees can remove masks if they feel comfortable doing so.
 

Engage on October 18 from 8 - 9AM ET | Hear from Sanofi leadership during a fireside chat about how Sanofi is evolving to meet the needs of an ever-changing innovation landscape. This livestreamed session will feature: 

  • John Reed, Executive Vice President, Global Head of Research and Development, Sanofi
  • Alban de La Sablière, Head of Partnering, Sanofi
  • Frank Nestle, Global Head of Research, Sanofi


Discover on October 18 from 3 - 4PM ET | Join Sanofi’s information session for the latest insights on its R&D strategy and therapeutic focus areas in immunology and inflammation (I&I) and cell and gene therapies. This hybrid session will feature:

  • John Bertin, Global Head of the Immunology and Inflammation Research Therapeutic Area, Sanofi
  • Christian Mueller, Global Head of Genomic Medicine Unit, Sanofi


Connect on October 18 & 19 | Meet one-on-one with Sanofi representatives to discuss collaboration opportunities. Sanofi’s specific areas of interest are: 

  • Cell and gene therapies, including gene editing and non-viral delivery technologies 
  • Immunology and inflammation, with a focus on dermatology, respiratory, and gastro-intestinal indications   


Eligibility Guidelines
Sanofi is open to connecting with groundbreaking innovators across all stages of development that have a strong understanding of their technology’s path to product. Sanofi is particularly interested in tangible assets or disruptive technologies.

Protection of intellectual property rights (ex. patents, trademarks, copyright, trade secrets, etc.) of your concept is your responsibility and your responsibility alone. Information you include in your application will be shared with Sanofi representatives. Please note that these representatives did NOT sign Non-Disclosure Agreements (NDAs). Therefore, you should not include any information in your application that you feel could be harmful to your company should that information be disclosed. 

 MassBioHub & Virtual, 700 Technology Sq Fl 5 Cambridge MA 02139
Global Head of Research, Sanofi
Frank O. Nestle, M.D. FMedSci is currently Global Head of Research and Chief Scientific Officer at Sanofi with responsibility for Sanofi’s main therapeutic areas of Immunology & Inflammation, Oncology including Immuno-Oncology, Neurology, Rare Diseases, Hematology and Genomic Medicine with a mandate to innovate and accelerate first and best in class medicines from discovery to clinical translation. Frank joined Sanofi in 2016 as founding Therapeutic Area Head for Immunology & Inflammation Research where he established the current organizational structure, recruited a cadre of leading immune-scientists and built a portfolio of first and best in class clinical candidate molecules with 15 immunology new molecular entities currently in clinical Development. Before joining Sanofi, Frank was a Professor and Chair of Cutaneous Medicine at King’s College London (United Kingdom) and practiced medicine at Guy’s and St. Thomas’ Hospital, the leading UK University Hospital, where he was also a member of the Board of Directors. At King’s College, Frank led research, translational clinical trials, and teams in Dermatology, Allergology and Immunology. In addition, he held several executive roles, in particular at the Guy’s and St Thomas’ Biomedical Research Center. He built the Clinical Research Facilities and led the Biomarker and Co-Diagnostics Cluster overseeing cross-disease area precision medicine projects and translational research platforms including Genomics, Flow Cytometry, Translational Bioinformatics and Bioresource. Frank is a Fellow of the Academy of Medical Sciences, a Senior Investigator Emeritus at the National Institute for Health Research (NIHR) and Past-President of the Federation of Clinical Immunology Societies (FOCIS).

Brought to you by